Cargando…

Prevalence, treatment patterns, and healthcare resource utilization in Medicare and commercially insured non-dialysis-dependent chronic kidney disease patients with and without anemia in the United States

BACKGROUND: Anemia is common in non-dialysis-dependent chronic kidney disease (NDD-CKD) patients, but detailed information on prevalence and treatment is lacking. METHODS: We evaluated anemia prevalence and treatment using two datasets: the Medicare 20% random sample (ages 66–85 years), and the Truv...

Descripción completa

Detalles Bibliográficos
Autores principales:	St. Peter, Wendy L., Guo, Haifeng, Kabadi, Shaum, Gilbertson, David T., Peng, Yi, Pendergraft, Trudy, Li, Suying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856223/ https://www.ncbi.nlm.nih.gov/pubmed/29544446 http://dx.doi.org/10.1186/s12882-018-0861-1

Ejemplares similares

Treatment patterns, adverse events, healthcare resource use and costs among commercially insured patients with mantle cell lymphoma in the United States
por: Kabadi, Shaum M., et al.
Publicado: (2019)

Associations of anemia persistency with medical expenditures in Medicare ESRD patients on dialysis
por: Liu, Jiannong, et al.
Publicado: (2009)

Incident colorectal cancer screening and associated healthcare resource utilization and Medicare cost among Medicare beneficiaries aged 66–75 years in 2016–2018
por: Li, Suying, et al.
Publicado: (2022)

1019. Healthcare Resource Utilization and Cost of People Living with HIV (PLWH) in US Commercial and Medicare Advantage Health Plans
por: Priest, Julie, et al.
Publicado: (2020)

Predialysis anemia management and outcomes following dialysis initiation: A retrospective cohort analysis
por: Wetmore, James B., et al.
Publicado: (2018)

Multiple Comorbidities, Psychiatric Disorders, Healthcare Resource Utilization and Costs Among Adults with Essential Tremor: A Retrospective Observational Study in a Large US Commercially Insured and Medicare Advantage Population
por: Dai, Dingwei, et al.
Publicado: (2022)

Use of Telemedicine for Buprenorphine Inductions in Patients With Commercial Insurance or Medicare Advantage
por: Barsky, Benjamin A., et al.
Publicado: (2022)

Comorbidity Associations with AATD Among Commercially Insured and Medicare Beneficiaries with COPD in the US
por: Sandhaus, Robert, et al.
Publicado: (2020)

Trends in Testosterone Prescriptions for Older Men Enrolled in Commercial Insurance and Medicare Advantage
por: Everhart, Alexander, et al.
Publicado: (2021)

Healthcare Utilization and Cost Burden of Porphyria in Commercially Insured Adults in the United States
por: Elsaid, Mohamed I., et al.
Publicado: (2020)

A retrospective analysis to estimate the healthcare resource utilization and cost associated with treatment-resistant depression in commercially insured US patients
por: Li, Gang, et al.
Publicado: (2020)

Healthcare resource utilization and costs before and after long-acting injectable antipsychotic initiation in commercially insured young adults with schizophrenia
por: Fu, Alex Z., et al.
Publicado: (2022)

Overall survival, adverse events, and economic burden in patients with chronic lymphocytic leukemia receiving systemic therapy: Real‐world evidence from the medicare population
por: Goyal, Ravi K., et al.
Publicado: (2021)

Changes in Healthcare Resource Use and Costs in Commercially Insured Insomnia Patients Initiating Suvorexant
por: Kale, Hrishikesh P., et al.
Publicado: (2021)

Treatment patterns, adverse events, and economic burden in a privately insured population of patients with chronic lymphocytic leukemia in the United States
por: Kabadi, Shaum M., et al.
Publicado: (2019)

Impact of Oxycodone HCl Extended-release Formulary Restrictions on Extended-release Opioid Market Share, Healthcare Resource Utilization and Costs in Commercial and Medicare Plans
por: Wade, Rolin L., et al.
Publicado: (2017)

Utilization of Positive and Negative Controls to Examine Comorbid Associations in Observational Database Studies
por: Desai, Jigar R., et al.
Publicado: (2017)

Comparison of Diabetes Medications Used by Adults With Commercial Insurance vs Medicare Advantage, 2016 to 2019
por: McCoy, Rozalina G., et al.
Publicado: (2021)

Evaluation of Potentially Avoidable Acute Care Utilization Among Patients Insured by Medicare Advantage vs Traditional Medicare
por: Beckman, Adam L., et al.
Publicado: (2023)

Healthcare Resource Utilization and Costs Among Commercially Insured Patients With Advanced or Recurrent Endometrial Cancer Initiating First-Line Therapy in the United States
por: Kobayashi, Monica, et al.
Publicado: (2023)

Cost trends among commercially insured and Medicare Advantage-insured patients with chronic obstructive pulmonary disease: 2006 through 2009
por: Dalal, Anand A, et al.
Publicado: (2011)

More surgery in December among US patients with commercial insurance is offset by unrelated but lesser surgery among patients with Medicare insurance
por: Dexter, Franklin, et al.
Publicado: (2022)

Healthcare costs and utilization for Medicare beneficiaries with Alzheimer's
por: Zhao, Yang, et al.
Publicado: (2008)

Cost Sharing, Supplementary Insurance, and Health Services Utilization Among the Medicare Elderly
por: Link, Charles R., et al.
Publicado: (1980)

Mortality, healthcare resource utilization, and cost among Medicare beneficiaries with Clostridioides difficile infection with and without sepsis
por: Amin, Alpesh, et al.
Publicado: (2022)

Immune checkpoint inhibitors: immune-related adverse events, healthcare utilization, and costs among commercial and Medicare Advantage patients
por: Gunturu, Krishna S., et al.
Publicado: (2022)

Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: an administrative claims analysis
por: Smoyer-Tomic, Karen E, et al.
Publicado: (2012)

1691. Pre- and Post-Hospitalization Resource Utilization and Costs Associated with Urinary Tract Infection (UTI) in both Commercial and Medicare Populations
por: Melnick, David, et al.
Publicado: (2020)

Trends in opioid use in commercially insured and Medicare Advantage populations in 2007-16: retrospective cohort study
por: Jeffery, Molly Moore, et al.
Publicado: (2018)

Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance
por: DiStefano, Michael J., et al.
Publicado: (2023)

Impact of Medicare payment policy on home health resources utilization
por: Irvine, Audrey, et al.
Publicado: (1991)

915 Is a hospital's surgical site infection rate among Medicare-insured patients a good indicator of outcome for commercially-insured patients?
por: Calderwood, Michael S., et al.
Publicado: (2014)

Joint Effects of Obesity and Vitamin D Insufficiency on Insulin Resistance and Type 2 Diabetes: Results from the NHANES 2001–2006
por: Kabadi, Shaum M., et al.
Publicado: (2012)

Characterization of Heavily Treatment-Experienced People With HIV and Impact on Health Care Resource Utilization in US Commercial and Medicare Advantage Health Plans
por: Priest, Julie, et al.
Publicado: (2021)

Medicare advantage and dialysis facility choice
por: Marr, Jeffrey, et al.
Publicado: (2023)

The cost burden of oral, oral pharyngeal, and salivary gland cancers in three groups: commercial insurance, medicare, and medicaid
por: Jacobson, Jed J, et al.
Publicado: (2012)

Prescription Drug Coverage for Treatment of Low Back Pain Among US Medicaid, Medicare Advantage, and Commercial Insurers
por: Lin, Dora H., et al.
Publicado: (2018)

Medical Claim Cost Impact of Improved Diabetes Control for Medicare and Commercially Insured Patients with Type 2 Diabetes
por: Fitch, Kathryn, et al.
Publicado: (2013)

Impact of discontinuity in health insurance on resource utilization
por: Banerjee, Ritesh, et al.
Publicado: (2010)

Healthcare use in commercially insured youth with mental health disorders
por: Hugunin, Julie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ek5i31tvo325jnq5jbto5hvdte